Arch Iran Med. 2019;22(1):32-38.
PMID: 30821158
Scopus id: 85062435057
  Abstract View: 195
  PDF Download: 234

Original Article

TMEM16A as a Potential Biomarker in the Diagnosis and Prognosis of Lung Cancer 

Cong Hu 1, Ronggui Zhang 2, Depeng Jiang 3 *

1 Department of Intensive Care, Zhuhai People’s Hospital, The Third Affiliated Hospital, Jinan University, Zhuhai, 519000, China
2 Department of Urology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China
3 Department of Respiratory Medicine, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China

Abstract

Background: Transmembrane protein 16A (TMEM16A), also known as ANO1 (anoctamin-1), was reported to be vital in the growth and invasion of several malignancies. However, role of TMEM16A in lung cancer remained unclear. The aim of this study was to evaluate the expression of TMEM16A and its significance in lung cancer.

Methods: qRT-PCR and Western blots were performed to evaluate the TMEM16A mRNA and protein expression. Proliferation and invasion of H1299 cancer cells were evaluated by CCK-8 and transwell assays. Tumor volumes in nude mice implanted with H1299 cells were assessed once every week for 5 weeks by measuring 2 perpendicular dimensions. Immunofluorescent staining revealed expression of TMEM16A in nude mice cancer tissues.

Results: Our findings provided compelling evidence that TMEM16A production in H1299 cells is 2.1 times higher than observations in HBE16 cells. We showed that overexpression of TMEM16A contributed to the proliferation of H1299 cells. Moreover, T16Ainh-A01, a specific TMEM16A inhibitor or shRNA targeting TMEM16A somewhat inhibited lung tumor cell growth and invasion as evident from in vitro studies and from in vivo xenograft-tumor growth. Inhibition of TMEM16A strongly suppressed EGFR phosphorylation and growth of lung cancer cells. Furthermore, a reduction of p-RAS and p-ERK1/2 was also observed.

Conclusion: TMEM16A promoted growth and invasion in lung cancer cells via an EGFR/ MAPK-dependent signaling pathway. So we infer TMEM16A membrane protein may have potential to serve as a biomarker in lung cancer.

Cite this article as: Hu C, Zhang R, Jiang D. TMEM16A as a potential biomarker in the diagnosis and prognosis of lung cancer. Arch Iran Med. 2019;22(1):32–38.
First name
 
Last name
 
Email address
 
Comments
 
Security code


Article Viewed: 195

Your browser does not support the canvas element.


PDF Downloaded: 234

Your browser does not support the canvas element.

Submitted: 01 Jan 2018
Accepted: 25 Apr 2018
First published online: 01 Jan 2019
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)